KE
Kalif Eliyahu Sharon
首席财务官
OtherM
内部人交易记录
高级管理人员尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Kalif Eliyahu Sharon, 首席财务官. Director active across 1 company, notably Teva Pharmaceutical Industries Ltd. Aggregated, 20 filings have been logged. Split: 0 buy · 5 sells. Total volume traded: €12.4m. Activity tracked since 22 August 2022. The latest transaction was filed on 26 February 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Kalif Eliyahu Sharon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报20 总计
19,916 股Ordinary SharesSEC:0001193125-26-098573:0
33,512 股Ordinary SharesSEC:0001193125-26-096513:0
49,800 股Ordinary SharesSEC:0001193125-26-093903:0
345,810 股@ US$33.644879.3% 占其流量Ordinary SharesSEC:0001193125-26-085343:0
55,775 股@ US$17.076932.0% 占其流量Ordinary SharesSEC:0000950170-25-086697:0
21,390 股Ordinary SharesSEC:0000950170-25-035528:0
33,512 股Ordinary SharesSEC:0000950170-25-034651:0
55,750 股@ US$16.205649.9% 占其流量Ordinary SharesSEC:0000950170-25-031946:0
52,320 股Ordinary SharesSEC:0000950170-24-028015:0
49,800 股Ordinary SharesSEC:0000950170-24-025888:0
18,430 股Ordinary SharesSEC:0000950170-24-023530:0
6,630 股Ordinary SharesSEC:0000950170-24-015601:0
35,125 股@ US$9.733517.8% 占其流量Ordinary SharesSEC:0001209191-23-045156:0
33,512 股Ordinary SharesSEC:0001209191-23-016712:0
18,430 股Ordinary SharesSEC:0001209191-23-014439:0
6,629 股Ordinary SharesSEC:0001209191-23-009613:0
55,500 股@ US$10.066632.3% 占其流量Ordinary SharesSEC:0001209191-22-047291:0
21,387 股Ordinary SharesSEC:0001209191-22-017054:0
18,430 股Ordinary SharesSEC:0001209191-22-014471:0
6,629 股Ordinary SharesSEC:0001209191-22-009630:0
About Kalif Eliyahu Sharon
Kalif Eliyahu Sharon is Executive Vice-President and Chief Financial Officer. He is associated with Teva Pharmaceutical Industries Ltd, and his 20 filings include, in the recent sampled filings held, sales totaling EUR 12410279 between 2022-02-15 and 2026-03-09. The most frequent transaction nature is Options exercise.